Search results for: Italy
Filter search results
Around The World in HTAs: Italy – What’s Next?
20 April 2023
The health system in Italy Italy has a universal national health system, mainly funded by taxes (Italian National Health Service, NHS). The Italian NHS is organised in two levels, national…
OHE at ISPOR Italy Chapter – Rome: Are Wider Societal Effects Considered in Healthcare Decision-making?
17 May 2016
…at the ISPOR Italy Chapter – Rome conference on the topic of the inclusion of wider societal effects in public investment decision making in Italy. A key example of a…
Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
1 December 2016
Published paper using MCDA to obtain preferences on decision criteria across three stakeholder groups (patients, clinicians and payers) in Italy and to assess the value of obinutuzumab for rituximab-refractory iNHL….
Important Variations in Access to Orphan Drugs in France, Italy, Germany, Spain and the UK
14 March 2017
A new OHE report compares the availability and access of orphan medicinal products (OMPs) in the UK, France, Germany, Italy and Spain. A new OHE Consulting Report has been published…
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
Most countries regulate manufacturer prices for pharmaceuticals, either directly (France, Italy) or indirectly through controls on reimbursement (Germany, Japan) or profits (the UK). It is widely believed that drug prices…
OHE at HTAi 2017: Meet the Team
13 June 2017
The HTAi Annual Meeting 2017 will be held in Rome, Italy, 17-21st June 2017. The theme of the meeting is Towards an HTA Ecosystem: From Local Needs to Global Opportunities….
OHE at HTAi Rome
12 July 2017
…2017 held in Rome, Italy, 17-21st June 2017, are available below. The theme of the meeting was Towards an HTA Ecosystem: From Local Needs to Global Opportunities. Adrian Towse participated…
Data Governance Arrangements for Real-World Evidence in Japan
1 September 2019
…Italy, Sweden, the Netherlands, the UK and the US1. Two years later, Lilly commissioned a second report based on the South Korean setting, following the same method and structure as…
The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics
12 October 2022
…represent each country’s individual contribution; Line represents each country’s share in percentages; Green bar represents the EU contribution, including Germany, France, and Italy; To avoid double-counting the GDP of Germany,…